Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5221_Библиотеки_им_академика_М_И_Перельмана.pdf

Infectious Disease and Neurocognition
HELMER, C., PASQUIER, F. & DARTIGUES, J. F. 2006. [Epidemiology of Alzheimer disease and re-
lated disorders]. Med Sci (Paris), 22, 288– 296.
HIRAI, Y., HAQUE, M., YOSHIDA, T., YOKOTA, K., YASUDA, T. & OGUMA, K. 1995. Unique
cholesteryl glucosides in Helicobacter pylori: Composition and structural analysis. J Bacteriol, 177,
5327– 5333.
HONJO, K., VAN REEKUM, R. & VERHOEFF, N. P. 2009. Alzheimer’s disease and infection: Do in-
fectious agents contribute to progression of Alzheimer’s disease? Alzheimers Dement, 5, 348– 360.
HUANG, W. S., YANG, T. Y., SHEN, W. C., LIN, C. L., LIN, M. C. & KAO, C. H. 2014. Association be-
tween Helicobacter pylori infection and dementia. J Clin Neurosci, 21, 1355– 1358.
JARUVONGVANICH, V., SANGUANKEO, A., JARUVONGVANICH, S. & UPALA, S. 2016.
Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and
meta- analysis. Mult Scler Relat Disord, 7, 92– 97.
KATE, V., ANANTHAKRISHNAN, N. & TOVEY, F. I. 2013. Is Helicobacter pylori infection the pri-
mary cause of duodenal ulceration or a secondary factor? A review of the evidence. Gastroenterol Res
Pract, 2013, 425840.
KAYALI, S., MANFREDI, M., GAIANI, F., BIANCHI, L., BIZZARRI, B., LEANDRO, G., DI MARIO,
F. & DE’ ANGELIS, G. L. 2018. Helicobacter pylori, transmission routes and recurrence of infec-
tion: State of the art. Acta Biomed, 89, 72– 76.
KESSLER R. C., BERGLUND P., DEMLER O., JIN R., MERIKANGAS K. R., WALTERS E. E., Lifetime
prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey
Replication [published correction appears in Arch Gen Psychiatry. 2005 Jul;62(7):768. Merikangas,
Kathleen R [added]]. Arch Gen Psychiatry. 2005;62(6):593-602. doi:10.1001/archpsyc.62.6.593.
KESSLER R. C., MCGONAGLE K. A., ZHAO S., et al. Lifetime and 12-month prevalence of DSM-III-R
psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen
Psychiatry. 1994;51(1):8–19.
KIANI, S., VAKILIAN, A., KAMIAB, Z. & SHAMSIZADEH, A. 2020. Correlation of dietary intake and
Helicobacter pylori infection with multiple sclerosis, a case- control study in Rafsanjan, Iran, 2017–
18. Qatar Med J, 2020, 45.
KIRA, J. 2015. Helicobacter pylori infection might prove the hygiene hypothesis in multiple sclerosis. J
Neurol Neurosurg Psychiatry, 86, 591– 592.
KOUNTOURAS, J., BOZIKI, M., GAVALAS, E., ZAVOS, C., DERETZI, G., CHATZIGEORGIOU, S.,
KATSINELOS, P., GRIGORIADIS, N., GIARTZA- TAXIDOU, E. & VENIZELOS, I. 2010. Five- year
survival aer Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol, 23,
199– 204.
KOUNTOURAS, J., BOZIKI, M., GAVALAS, E., ZAVOS, C., DERETZI, G., GRIGORIADIS,
N., TSOLAKI, M., CHATZOPOULOS, D., KATSINELOS, P., TZILVES, D., ZABOURI, A. &
MICHAILIDOU, I. 2009a. Increased cerebrospinal uid Helicobacter pylori antibody in Alzheimer’s
disease. Int J Neurosci, 119, 765– 777.
KOUNTOURAS, J., BOZIKI, M., GAVALAS, E., ZAVOS, C., GRIGORIADIS, N., DERETZI, G.,
TZILVES, D., KATSINELOS, P., TSOLAKI, M., CHATZOPOULOS, D. & VENIZELOS, I. 2009b.
Eradication of Helicobacter pylori may be benecial in the management of Alzheimer’s disease. J
Neurol, 256, 758– 767.
KOUNTOURAS, J., GAVALAS, E., BOZIKI, M. & ZAVOS, C. 2007a. Helicobacter pylori may be in-
volved in cognitive impairment and dementia development through induction of atrophic gastritis,
vitamin B- 12 folate deciency, and hyperhomocysteinemia sequence. Am J Clin Nutr, 86, 805– 806.
KOUNTOURAS, J., GAVALAS, E., ZAVOS, C., STERGIOPOULOS, C., CHATZOPOULOS, D.,
KAPETANAKIS, N. & GISAKIS, D. 2007b. Alzheimer’s disease and Helicobacter pylori infec-
tion: Defective immune regulation and apoptosis as proposed common links. Med Hypotheses, 68,
378– 388.
KOUNTOURAS, J., PAPAEFTHYMIOU, A., GAVALAS, E., POLYZOS, S. A., BOZIKI, M.,
KYRIAKOU, P., KATSINELOS, P., ZAVOS, C., LIATSOS, C., TZIVRAS, D., TZITIRIDOU-
CHATZOPOULOU, M., DARDIOTIS, E., DERETZI, G., VARDAKA, E. & DOULBERIS, M. 2020.
Helicobacter pylori infection as a potential risk factor for multiple sclerosis. Med Hypotheses, 143,
110135.

Helicobacter pylori 159
KOUNTOURAS, J., TSOLAKI, M., BOZIKI, M., GAVALAS, E., ZAVOS, C., STERGIOPOULOS,
C., KAPETANAKIS, N., CHATZOPOULOS, D. & VENIZELOS, I. 2007c. Association between
Helicobacter pylori infection and mild cognitive impairment. Eur J Neurol, 14, 976– 982.
KOUNTOURAS, J., TSOLAKI, M., GAVALAS, E., BOZIKI, M., ZAVOS, C., KARATZOGLOU, P.,
CHATZOPOULOS, D. & VENIZELOS, I. 2006. Relationship between Helicobacter pylori infection
and Alzheimer disease. Neurology, 66, 938– 940.
KOUNTOURAS, J., ZAVOS, C., GAVALAS, E., BOZIKI, M. & KATSINELOS, P. 2008. Helicobacter
pylori may hold a variable role in multiple sclerosis based on ethnicity. Med Hypotheses, 71, 614– 615.
LACY, B. E. & ROSEMORE, J. 2001. Helicobacter pylori: Ulcers and more: e beginning of an era. J
Nu tr, 131, 2789S– 2793S.
LANGER- GOULD, A. M., GONZALES, E. G., SMITH, J. B., LI, B. H. & NELSON, L. M. 2022. Racial
and ethnic disparities in multiple sclerosis prevalence. Neurology, 98, e1818– e1827.
LEVITT, M., SPECTOR, S., SJOERDSMA, A. & UDENFRIEND, S. 1965. Elucidation of the rate-
limiting step in norepinephrine biosynthesis in the perfused guinea- pig heart. J Pharmacol Exp er,
148, 1– 8.
LINDEBOOM, J. & WEINSTEIN, H. 2004. Neuropsychology of cognitive ageing, minimal cognitive
impairment, Alzheimer’s disease, and vascular cognitive impairment. Eur J Pharmacol, 490, 83– 86.
LIU, N. Y., SUN, J. H., JIANG, X. F. & LI, H. 2021. Helicobacter pylori infection and risk for developing
dementia: An evidence- based meta- analysis of case- control and cohort studies. Aging (Albany NY),
13, 22571– 22587.
LIVINGSTON, G., HUNTLEY, J., SOMMERLAD, A., AMES, D., BALLARD, C., BANERJEE, S.,
BRAYNE, C., BURNS, A., COHEN- MANSFIELD, J., COOPER, C., COSTAFREDA, S. G., DIAS,
A., FOX, N., GITLIN, L. N., HOWARD, R., KALES, H. C., KIVIMAKI, M., LARSON, E. B.,
OGUNNIYI, A., ORGETA, V., RITCHIE, K., ROCKWOOD, K., SAMPSON, E. L., SAMUS, Q.,
SCHNEIDER, L. S., SELBAEK, G., TERI, L. & MUKADAM, N. 2020. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet, 396, 413– 446.
MALAGUARNERA, M., BELLA, R., ALAGONA, G., FERRI, R., CARNEMOLLA, A. & PENNISI, G.
2004. Helicobacter pylori and Alzheimer’s disease: A possible link. Eur J Intern Med, 15, 381– 386.
MARSHALL, B. J. & WARREN, J. R. 1984. Unidentied curved bacilli in the stomach of patients with
gastritis and peptic ulceration. Lancet, 1, 1311– 1135.
MARTINEZ- RAMIREZ, D., GIUGNI, J. C., ALMEIDA, L., WALZ, R., AHMED, B., CHAI, F. A.,
RUNDLE- GONZALEZ, V., BONA, A. R., MONARI, E., WAGLE SHUKLA, A., HESS, C. W., HASS,
C. J. & OKUN, M. S. 2016. Association between antidepressants and falls in Parkinson’s disease. J
Neurol, 263, 76– 82.
MEEUS, B., VERSTRAETEN, A., CROSIERS, D., ENGELBORGHS, S., VAN DEN BROECK, M.,
MATTHEIJSSENS, M., PEETERS, K., CORSMIT, E., ELINCK, E., PICKUT, B., VANDENBERGHE,
R., CRAS, P., DE DEYN, P. P., VAN BROECKHOVEN, C. & THEUNS, J. 2012. DLB and PDD: A role
for mutations in dementia and Parkinson disease genes? Neurobiol Aging, 33, 629 e5– 629.e18.
MENG, L., SHEN, L. & JI, H. F. 2019. Impact of infection on risk of Parkinson’s disease: A quantitative
assessment of case- control and cohort studies. J Neurovirol, 25, 221– 228.
MORAN, A. P. & PRENDERGAST, M. M. 2001. Molecular mimicry in Campylobacter jejuni and
Helicobacter pylori lipopolysaccharides: Contribution of gastrointestinal infections to autoimmunity. J Autoimmun, 16, 241– 256.
NAGGA, K., RAJANI, R., MARDH, E., BORCH, K., MARDH, S. & MARCUSSON, J. 2003. Cobalamin,
folate, methylmalonic acid, homocysteine, and gastritis markers in dementia. Dement Geriatr Cogn
Disord, 16, 269– 275.
OKUBO, H., AKIYAMA, J., KOBAYAKAWA, M., KAWAZOE, M., MISHIMA, S., TAKASAKI, Y.,
NAGATA, N., SHIMADA, T., YOKOI, C., KOMORI, S., KIMURA, K., HISADA, Y., IWATA, E.,
WATANABE, K., YANAGISAWA, N., SHIROMA, S., SHIMOMURA, A., OKAHARA, K., CHO, H.
& UEMURA, N. 2020. Vonoprazan- based triple therapy is eective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility. J Gastroenterol, 55, 1054– 1061.
OSSOWSKA, K. & LORENC- KOCI, E. 2013. Depression in Parkinson’s disease. Pharmacol Rep, 65,
1545– 1557.

Infectious Disease and Neurocognition
PANAGIOTAKOS, D. B., PITSAVOS, C., CHRYSOHOOU, C., TSETSEKOU, E., PAPAGEORGIOU,
C., CHRISTODOULOU, G., STEFANADIS, C. & STUDY, A. 2004. Inammation, coagulation, and
depressive symptomatology in cardiovascular disease- free people; the ATTICA study. Eur Heart J,
25, 492– 499.
PANDEY, R., MISRA, V., MISRA, S. P., DWIVEDI, M., KUMAR, A. & TIWARI, B. K. 2010. Helicobacter
pylori and gastric cancer. Asian Pac J Cancer Prev, 11, 583– 588.
PARK, A. M., OMURA, S., FUJITA, M., SATO, F. & TSUNODA, I. 2017. Helicobacter pylori and gut
microbiota in multiple sclerosis versus Alzheimer’s disease: 10 pitfalls of microbiome studies. Clin
Exp Neuroimmunol, 8, 215– 232.
PARK, J., KIM, T. J., SONG, J. H., JANG, H., KIM, J. S., KANG, S. H., KIM, H. R., HWANGBO, S.,
SHIN, H. Y., NA, D. L., SEO, S. W., KIM, H. J. & KIM, J. J. 2021. Helicobacter pylori infection is asso-
ciated with neurodegeneration in cognitively normal men. J Alzheimers Dis, 82, 1591– 1599.
PAYAO, S. L. & RASMUSSEN, L. T. 2016. Helicobacter pylori and its reservoirs: A correlation with the
gastric infection. World J Gastrointest Pharmacol er, 7, 126– 132.
PEDRINI, M. J., SEEWANN, A., BENNETT, K. A., WOOD, A. J., JAMES, I., BURTON, J., MARSHALL,
B. J., CARROLL, W. M. & KERMODE, A. G. 2015. Helicobacter pylori infection as a protective factor
against multiple sclerosis risk in females. J Neurol Neurosurg Psychiatry, 86, 603– 607.
PIEKUT, T., HURLA, M., BANASZEK, N., SZEJN, P., DORSZEWSKA, J., KOZUBSKI, W. &
PRENDECKI, M. 2022. Infectious agents and Alzheimer’s disease. J Integr Neurosci, 21, 73.
PIERANTOZZI, M., PIETROIUSTI, A., GALANTE, A., SANCESARIO, G., LUNARDI, G., FEDELE,
E., GIACOMINI, P. & STANZIONE, P. 2001. Helicobacter pylori- induced reduction of acute levo-
dopa absorption in Parkinson’s disease patients. Ann Neurol, 50, 686– 687.
PRINCE, M., BRYCE, R., ALBANESE, E., WIMO, A., RIBEIRO, W. & FERRI, C. P. 2013. e global
prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement, 9, 63– 75 e2.
ROKKAS, T., GISBERT, J. P., MALFERTHEINER, P., NIV, Y., GASBARRINI, A., LEJA, M., MEGRAUD,
F., O’MORAIN, C. & GRAHAM, D. Y. 2021. Comparative eectiveness of multiple dierent rst- line
treatment regimens for Helicobacter pylori infection: A network meta- analysis. Gastroenterology,
161, 495– 507.e4.
ROUBAUD-BAUDRON, C., LETENNEUR, L., LANGLAIS, A., BUISSONNIERE, A., MEGRAUD, F.,
DARTIGUES, J. F., SALLES, N. & PERSONNES AGÉES QUID STUDY. 2013. Does Helicobacter
pylori infection increase incidence of dementia? e Personnes Agées QUID Study. J Am Geriatr
Soc, 61, 74– 78.
ROUBAUD- BAUDRON, C., KROLAK- SALMON, P., QUADRIO, I., MEGRAUD, F. & SALLES, N.
2012. Impact of chronic Helicobacter pylori infection on Alzheimer’s disease: Preliminary results.
Neurobiol Aging, 33, 1009.e11– 19.
RYU, K. H., YI, S. Y., NA, Y. J., BAIK, S. J., YOON, S. J., JUNG, H. S. & SONG, H. J. 2010. Reinfection rate
and endoscopic changes aer successful eradication of Helicobacter pylori. World J Gastroenterol,
16, 251– 255.
SANTARELLI, L., GABRIELLI, M., CREMONINI, F., SANTOLIQUIDO, A., CANDELLI, M.,
NISTA, E. C., POLA, P., GASBARRINI, G. & GASBARRINI, A. 2004. Atrophic gastritis as a cause of
hyperhomocysteinaemia. Aliment Pharmacol er, 19, 107– 111.
SCHULZ, J. D., HAWKES, E. L. & SHAW, C. A. 2006. Cycad toxins, Helicobacter pylori and parkin-
sonism: Cholesterol glucosides as the common denomenator. Med Hypotheses, 66, 1222– 1226.
SCHWARZ, S., MORELLI, G., KUSECEK, B., MANICA, A., BALLOUX, F., OWEN, R. J., GRAHAM,
D. Y., VAN DER MERWE, S., ACHTMAN, M. & SUERBAUM, S. 2008. Horizontal versus familial
transmission of Helicobacter pylori. PLoS Pathog, 4, e1000180.
SHAMIM, S. A., WARRIACH, Z. I., TARIQ, M. A., RANA, K. F. & MALIK, B. H. 2019. Insomnia: Risk
factor for neurodegenerative diseases. Cureus, 11, e6004.
SHEN, S., ZHANG, C., XU, Y. M. & SHI, C. H. 2022. e role of pathogens and anti- infective agents in
Parkinson’s disease, from etiology to therapeutic implications. J Parkinsons Dis, 12, 27– 44.
SHEN, X., YANG, H., WU, Y., ZHANG, D. & JIANG, H. 2017. Meta- analysis: Association of
Helicobacter pylori infection with Parkinson’s diseases. Helicobacter, 22, e12398.
SHEU, B. S., SHIESH, S. C., YANG, H. B., SU, I. J., CHEN, C. Y. & LIN, X. Z. 1997. Implications of
Helicobacter pylori serological titer for the histological severity of antral gastritis. Endoscopy,
29, 27– 30.

Helicobacter pylori 161
SHIOTA, S., MURAKAMI, K., YOSHIIWA, A., YAMAMOTO, K., OHNO, S., KURODA, A.,
MIZUKAMI, K., HANADA, K., OKIMOTO, T., KODAMA, M., ABE, K., YAMAOKA, Y. &
FUJIOKA, T. 2011. e relationship between Helicobacter pylori infection and Alzheimer’s disease
in Japan. J Neurol, 258, 1460– 1463.
SIMANEK, A. M., ZHENG, C., YOLKEN, R., HAAN, M. & AIELLO, A. E. 2019. A longitudinal study
of the association between persistent pathogens and incident depression among older U.S. Latinos. J
Gerontol A Biol Sci Med Sci, 74, 634– 641.
SOSA- ORTIZ, A. L., ACOSTA- CASTILLO, I. & PRINCE, M. J. 2012. Epidemiology of dementias and
Alzheimer’s disease. Arch Med Res, 43, 600– 608.
SZWED, P., GASECKA, A., ZAWADKA, M., EYILETEN, C., POSTULA, M., MAZUREK, T.,
SZARPAK, L. & FILIPIAK, K. J. 2021. Infections as novel risk factors of atherosclerotic cardiovascular diseases: Pathophysiological links and therapeutic implications. J Clin Med, 10, 2539.
TAFTI, D., EHSAN, M. & XIXIS, K. L. 2022. Multiple Sclerosis [Online]. StatPearls Publishing.
Available: https:// www.ncbi.nlm.nih.gov/ books/ NBK499 849/
TAKEOKA, A., TAYAMA, J., KOBAYASHI, M., SAGARA, I., OGAWA, S., SAIGO, T., HAYASHIDA,
M., YAMASAKI, H., FUKUDO, S. & SHIRABE, S. 2017. Psychological eects of Helicobacter
pylori- associated atrophic gastritis in patients under 50 years: A cross- sectional study. Helicobacter,
22, e12445.
TAN, A. H., LIM, S. Y., MAHADEVA, S., LOKE, M. F., TAN, J. Y., ANG, B. H., CHIN, K. P.,
MOHAMMAD ADNAN, A. F., ONG, S. M. C., IBRAHIM, A. I., ZULKIFLI, N., LEE, J. K., LIM, W.
T., TEO, Y. T., KOK, Y. L., NG, T. Y., TAN, A. G. S., ZULKIFLE, I. M., NG, C. K., EE, S. S., ARAFIN,
S., MOHAMAD SHUKORI, K., VADIVELU, J. S., MARRAS, C., FOX, S. H. & LANG, A. E. 2020.
Helicobacter pylori eradication in Parkinson’s disease: A randomized placebo- controlled trial. Mov
Disord, 35, 2250– 2260.
TAN, A. H., MAHADEVA, S., MARRAS, C., THALHA, A. M., KIEW, C. K., YEAT, C. M., NG, S. W.,
ANG, S. P., CHOW, S. K., LOKE, M. F., VADIVELU, J. S., IBRAHIM, N., YONG, H. S., TAN, C. T.,
FOX, S. H., LANG, A. E. & LIM, S. Y. 2015. Helicobacter pylori infection is associated with worse
severity of Parkinson’s disease. Parkinsonism Relat Disord, 21, 221– 225.
TSAI, C. F., CHEN, M. H., WANG, Y. P., LIU, P. Y., HOU, M. C., LEE, F. Y. & LU, C. L. 2021. Increased
risk of short- term depressive disorder aer Helicobacter pylori eradication: A population- based
nested cohort study. Helicobacter, 26, e12824.
TURNER, R. S. 2003. Biomarkers of Alzheimer’s disease and mild cognitive impairment: Are we there
yet? Exp Neurol, 183, 7– 10.
VIRAMETEEKUL, S., PHOKAEWVARANGKUL, O. & BHIDAYASIRI, R. 2021. Proling the most
elderly Parkinson’s disease patients: Does age or disease duration matter? PLoS One, 16, e0261302.
WANG, B., YU, M., ZHANG, R., CHEN, S., XI, Y. & DUAN, G. 2020a. A meta- analysis of the asso-
ciation between Helicobacter pylori infection and risk of atherosclerotic cardiovascular disease.
Helicobacter, 25, e12761.
WANG, H., LIU, X., TAN, C., ZHOU, W., JIANG, J., PENG, W., ZHOU, X., MO, L. & CHEN, L. 2020b.
Bacterial, viral, and fungal infection- related risk of Parkinson’s disease: Meta- analysis of cohort and
case- control studies. Brain Behav, 10, e01549.
WANG, X. L., ZENG, J., FENG, J., TIAN, Y. T., LIU, Y. J., QIU, M., YAN, X., YANG, Y., XIONG, Y.,
ZHANG, Z. H., WANG, Q., WANG, J. Z. & LIU, R. 2014. Helicobacter pylori ltrate impairs spatial
learning and memory in rats and increases beta- amyloid by enhancing expression of presenilin- 2.
Front Aging Neurosci, 6, 66.
WANG, X. L., ZENG, J., YANG, Y., XIONG, Y., ZHANG, Z. H., QIU, M., YAN, X., SUN, X. Y.,
TUO, Q. Z., LIU, R. & WANG, J. Z. 2015. Helicobacter pylori ltrate induces Alzheimer- like tau
hyperphosphorylation by activating glycogen synthase kinase- 3beta. J Alzheimers Dis, 43, 153– 165.
WHITE, A. R., HUANG, X., JOBLING, M. F., BARROW, C. J., BEYREUTHER, K., MASTERS, C.
L., BUSH, A. I. & CAPPAI, R. 2001. Homocysteine potentiates copper- and amyloid beta peptidemediated toxicity in primary neuronal cultures: Possible risk factors in the Alzheimer’s- type neurodegenerative pathways. J Neurochem, 76, 1509– 1520.
WORLD HEALTH ORGANIZATION. (2022). Depression and Other Common Mental Disorders:
Global Health Estimates. URL: Depression and Other Common Mental Disorders (who.int)

Infectious Disease and Neurocognition
WU, Y., MURRAY, G. K., BYRNE, E. M., SIDORENKO, J., VISSCHER, P. M. & WRAY, N. R. 2021.
GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal dis-
orders and depression. Nat Commun, 12, 1146.
WU, Y., ZHANG, L., LI, S. & ZHANG, D. 2022. Associations of dietary vitamin B1, vitamin B2, vitamin
B6, and vitamin B12 with the risk of depression: A systematic review and meta- analysis. Nutr R ev,
80, 351– 366.
YAO, G., WANG, P., LUO, X. D., YU, T. M., HARRIS, R. A. & ZHANG, X. M. 2016. Meta- analysis of
association between Helicobacter pylori infection and multiple sclerosis. Neurosci Lett, 620, 1– 7.
YUAN, W., BEAULIEU- JONES, B., KROLEWSKI, R., PALMER, N., VEYRAT- FOLLET, C., FRAU, F.,
COHEN, C., BOZZI, S., COGSWELL, M., KUMAR, D., COULOUVRAT, C., LEROY, B., FISCHER,
T. Z., SARDI, S. P., CHANDROSS, K. J., RUBIN, L. L., WILLS, A. M., KOHANE, I. & LIPNICK, S.
L. 2021. Accelerating diagnosis of Parkinson’s disease through risk prediction. BMC Neurol, 21, 201.
YUE, L., ZHANG, R., CHEN, S. & DUAN, G. 2023. Relationship between Helicobacter pylori and in-
cident hypertension as well as blood pressure: A systematic review and meta- analysis. Dig Dis, 41,
124– 137.
ZENG, M., MAO, X. H., LI, J. X., TONG, W. D., WANG, B., ZHANG, Y. J., GUO, G., ZHAO, Z. J., LI, L.,
WU, D. L., LU, D. S., TAN, Z. M., LIANG, H. Y., WU, C., LI, D. H., LUO, P., ZENG, H., ZHANG, W.
J., ZHANG, J. Y., GUO, B. T., ZHU, F. C. & ZOU, Q. M. 2015. Ecacy, safety, and immunogenicity of
an oral recombinant Helicobacter pylori vaccine in children in China: A randomised, double- blind,
placebo- controlled, phase 3 trial. Lancet, 386, 1457– 1464.
ZHONG, R., CHEN, Q., ZHANG, X., LI, M. & LIN, W. 2022. Helicobacter pylori infection is associated
with a poor response to levodopa in patients with Parkinson’s disease: A systematic review and meta-
analysis. J Neurol, 269, 703– 711.
ZILLI, E. M., O’DONNELL, A., SALINAS, J., APARICIO, H. J., GONZALES, M. M., JACOB, M.,
BEISER, A. & SESHADRI, S. 2021. Herpes labialis, Chlamydophila pneumoniae, Helicobacter
pylori, and Cytomegalovirus infections and risk of dementia: e Framingham Heart Study. J
Alzheimers Dis, 82, 593– 605.
ZUNSZAIN, P. A., HEPGUL, N. & PARIANTE, C. M. 2013. Inammation and depression. Curr Top
Behav Neurosci, 14, 135– 151.

12
Neurocognitive Dysfunction Associated
with Tuberculous Meningitis
Sofiati Dian and Paulus Anam Ong
Introduction
In 2022, there were 10.6 million people infected with tuberculosis (TB) worldwide (World Health Organization, 2023). TB aects the central nervous system in
1– 2 percent of cases (Mezochow et al., 2017), and global data show that TB results
in 12.1 disability- adjusted life- years (95 percent uncertainty interval (UI): 10.0–
14.9) lost by premature mortality and years lived with a disability for every TB case
incident— 6.3 (95 percent UI: 5.6– 7.0) years were aected by the illness episode and
5.8 (95 percent UI: 3.8– 8.3) years were from aer the illness episode (Menzies et al.,
2021). In some cases, TB can result in meningitis, which aected 164,000 (95 percent
UI: 129,000– 199,000) people worldwide in 2019, resulting in up to 50 percent mortality (Dodd et al., 2021). e British Medical Research Council classies TB meningitis (TBM) based on its severity: grade I TBM as a Glasgow coma score (GCS) of 15
with no focal neurology, grade II TBM as a GCS of 15 with a focal neurological deficit or a GCS of 11– 14, and grade III TBM as a GCS of 10. TBM can further result in
abnormalities in cognitive function (waites et al., 2004). Despite at least 9 months
of anti- TB therapy, neurological disabilities, including cognitive impairment, motor
decits, optic neuropathy, and other cranial nerve involvement, remain common
in the long- term follow- up of patients with TBM (Brancusi et al., 2012; Dian et al.,
2020; Li et al., 2017; M. Luo et al., 2018).
e relationship between cognitive decits and TBM can involve a focal brain lesion, including ischemia (Dian et al., 2020; Misra et al., 2011) of the TB zone secondary to vasculitis obliterans, intimal hyperplasia, a hypercoagulable state (Sy
et al., 2022), tuberculoma (Chen et al., 2015; Dian et al., 2021; Garcia- Grimshaw
et al., 2018), or diuse abnormalities including elevated intracranial pressure,
longstanding untreated hydrocephalus (Dev et al., 2019; Shankaragouda et al., 2013),
possible microvascular ischemia (Misra et al., 2011), subclinical meningoencephalitis, or persistent inammation leading to brain oedema (waites et al., 2000).
Meanwhile, the cognitive and psychiatric functions associated with TBM have yet
to be established. Some studies have reported that the cognitive abnormalities in
TBM are widespread and inuence more cognitive areas than only those that can be
Sofiati Dian and Paulus Anam Ong,
and Neuropsychiatric Medicine
© Oxford University Press 2024. DOI: 10.1093/ oso/ 9780192870414.003.0013

Infectious Disease and Neurocognition
attributed to focal structural decits alone. Further, neuroimaging ndings do not
always explain the cognitive decits associated with TBM (Davis et al., 2023).
ere are some limitations in fully identifying cognitive decits in patients with
TBM. First, various researchers from around the world have administered several
sets of cognitive tests with dierent sensitivities and specicities in various countries
and global situations. Second are variations in evaluation timing due to patients’
circumstances including anxiety or low mood (Santos et al., 2013), comorbidities
(visual impairment, hearing impairment, pain, dizziness) (Nightingale et al., 2021),
or fatigue. ird, there are no solid conrmatory modalities with which to correlate
the anatomical lesion to cognitive impairment in people with TBM.
Clinical features and cognitive abnormalities
associated with tuberculous meningitis
Despite the diculties in denitively describing the cognitive dysfunction associated with TBM, cognitive impairment in TBM appears to range from 12 to
93.3 percent (Anderson et al., 2010; Davis et al., 2023; Ganaraja et al., 2021; Quinn
et al., 2021), depending on the cognitive domain aected and the timing of the test.
Findings from countries including Mexico, India, the United States, Africa, and New
Zealand focusing on speech ability and cognitive function also have found associations between TBM and cognitive function. In a very early report from Mexico,
the authors found word- nding diculty associated with TBM (Booth & Curtis,
1893). Cognitive function measured within 2 weeks and at 1 year aer TBM diagnosis in India (Ganaraja et al., 2021), at 8 and 24 weeks aer TBM diagnosis in
Uganda (Quinn et al., 2021), 1 year aer TBM diagnosis in the United States in another early report (Hindsdale, 1901), 6 months aer TBM diagnosis in Africa (Davis
et al., 2023), and 18 months aer TBM diagnosis in New Zealand (Anderson et al.,
2010) has shown a variety of abnormalities including diculty with word nding as
identied by Booth and Curtis (1893), repetitive problems or conduction aphasia
(Garcia- Grimshaw et al., 2018), and recent memory loss (Booth & Curtis, 1893;
Shankaragouda et al., 2013). In many cases, the cognitive symptoms were not obviously present and became apparent only during the examination. e presenting
symptom in several publications is noncognitive, including headache, loss of consciousness, motor abnormalities, cranial nerve palsies, or seizures (Dian et al., 2020;
Imran et al., 2018; van Laarhoven et al., 2017).
Neuroanatomical abnormalities associated with TBM
TBM has been associated with decreased gray matter volume of the right thalamus,
right superior temporal gyrus, right precuneus, right middle temporal gyrus, le
putamen, right middle temporal gyrus (Chen et al., 2015), the arcuate fasciculus of

Tuberculous Meningitis 165
le parietal cortex (Garcia- Grimshaw et al., 2018), right caudate nucleus, and hypothalamus (Anderson et al., 2010) (Figure 12.1). Based on the most aected blood
vessels in TBM, the lenticulostriate arteries, middle cerebral arteries, and the thalamic perforators (Figure 12.2), the basal ganglia, cerebral cortex, pons, and cerebellum (Garcia- Grimshaw et al., 2018) are the areas most involved by ischemia in
TBM (Chen et al., 2015). Of those areas, abnormalities of the right thalamus, le
putamen, and right caudate nucleus are associated with worse cognitive function
(Chen et al., 2015).
Cognitive features associated with TBM
Recent ndings have shown that the main cognitive domains aected in people
with TBM who do not have human immunodeciency virus (HIV) are attention,
working memory, executive function, and learning memory (Chen et al., 2015;
Ganaraja et al., 2021; Quinn et al., 2021). Aer exclusion of patients with grade
II and III TBM and those with imaging features of hydrocephalus, arteritis, and
tuberculoma, a study in India found that learning memory and attention were the
most impaired cognitive functions in TBM (Chen et al., 2015). In addition, Chen
et al. also reported impairment in verbal comprehension, including general verbal
skills, verbal reasoning, the ability to understand and use verbal reasoning, verbal
knowledge, perceptual organization, and working memory (Chen et al., 2015).
In contrast, however, Davis et al. did not nd attention and working memory
decits in HIV- infected TBM (Davis et al., 2023). Although attention and working
memory decits are early indicators of subcortical impairment, Davis et al. (2023)
found primarily motor decits, suggesting subcortical abnormalities, so it is possible that insensitive neuropsychological testing resulted in the ndings of normal
attention and working memory. Further, only one tool was used in this study to
assess four cognitive domains. In contrast to earlier ndings, HIV- infected TBM
patients in Uganda predominantly showed decits in motor domains, processing
speed, verbal learning, and executive function (Quinn et al., 2021). In comparison, cognitive decits in other infectious diseases, such as from Covid- 19, primarily aect executive function, episodic and working memory, and attention.
Psychiatric impairment, including anxiety and depression, also can be present
(Serrano- Castro et al., 2022). is pattern of cognitive decits may be dierent
from the pattern of cognitive decits typically found in Alzheimer’s disease, that is,
memory (Jalbert et al., 2008), as attributed to the entorhinal cortex, hippocampus,
parietal lobe, isthmus of the cingulate gyrus, the temporal lobe, amygdala, temporal pole, corpus callosum, nucleus accumbens, and parahippocampal atrophy
(Pölsterl et al., 2023).

Postcentral gyrus
fusiform gyrus
Prefronta
Precentral gyrus
Cingulate gyrus
Precuneus
Insula
Thalamus
nucleus
Right caudate
Right superior
temporal gyrus
Claustrum
Le putamen and
nucleus
Red nucleus
Subthalamic
Right middle
globus pallidus
Parahippocampal and
Pons
Hippocampus
temporal gyrus
Parietal
Wernicke
l
cortex
Figure 12.1 Tuberculous meningitis has been associated with decreased gray matter volume of the right thalamus, right superior temporal gyrus, right
precuneus, right middle temporal gyrus, le putamen, right middle temporal gyrus (Chen et al., 2015), right caudate nucleus, and hypothalamus (Anderson
et al., 2010).
Source: Created with BioRender.com.

Tuberculous Meningitis 167
Thalamo-
al a.
Internal carotid a.
perforating
branches
Striate branches of
middle cerebral a.
Middle cerebral a.
Posterior
communicating a.
Figure 12.2 The most commonly aected vessels in TBM are the lenticulostriate arteries,
middle cerebral arteries, and thalamic perforate at tuberculosis zone secondary to vasculitis
obliterans, intimal hyperplasia, a hypercoagulable state.
Source: Created with BioRender.com.
Thalamus
Posterior cerebr
Attention
e pathophysiology of attention impairment in TBM is not fully understood. e
involvement of brain areas responsible for attention processing has been reported by
Chen et al. (2015). e smaller gray matter volume mainly aected the suitable hemisphere structures, such as the right thalamus and right superior temporal gyrus,
in TBM patients compared to controls, suggesting the disruption of subsystems of
orienting, attention selection (ignoring distractibility), and maintaining vigilance in
TBM patients (Chen et al., 2015).
William James, in 1890, dened attention as the mind’s possession of multiple
simultaneous objects or trains of thought in clear and vivid form (Fan & Posner,
2004). A testable model of attention processing proposed by Posner and Petersen
(1990) is crucial to understanding normal and disturbed attention. e attention
system has three subsystems: orienting, detecting, and alerting/ vigilance. Orienting
refers to sensory processes such as visual foveation of a stimulus, which relies on the
parietal cortex, superior colliculus, and pulvinar/ thalamus. e detection subsystem
detects targets that would undergo further information process using the anterior
cingulate cortex and lateral prefrontal cortex, while the alerting system maintains
general vigilance through the noradrenergic locus coeruleus inuences mainly on
the right hemisphere structures (Posner & Petersen, 1990).
A recent study using whole- brain functional magnetic resonance imaging (MRI),
diusion- weighted MRI, and whole- brain tractography found that the concentration
Соседние файлы в папке Библиотека им академика М.И. Перельмана
